Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20018538HPVENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS20013645HPVENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS44010891HTLV-1ENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS44023402HTLV-1ENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS44050984HTLV-1ENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS44050985HTLV-1ENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TVIS44050986HTLV-1ENSG00000196876.19protein_codingSCN8ANoNo6334Q6B4S4
Q9UQD0
TCGA Plot Options
Drug Information
GeneSCN8A
DrugBank IDDB00252
Drug NamePhenytoin
Target IDBE0002084
UniProt IDQ9UQD0
Regulation Typeinhibitor
PubMed IDs15805193
CitationsTate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, Thom M, Sen A, Shorvon SD, Sander JW, Wood NW, Goldstein DB: Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5507-12. Epub 2005 Apr 1.
GroupsApproved; Vet_approved
Direct ClassificationPhenylhydantoins
SMILESO=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
PathwaysFosphenytoin (Antiarrhythmic) Action Pathway; Fosphenytoin (Antiarrhythmic) Metabolism Pathway; Phenytoin (Antiarrhythmic) Action Pathway
PharmGKBPA450947
ChEMBLCHEMBL16